DK0991945T4 - Fremgangsmåde til identifikation af tumor-antigener med autoantistoffer i serum - Google Patents

Fremgangsmåde til identifikation af tumor-antigener med autoantistoffer i serum

Info

Publication number
DK0991945T4
DK0991945T4 DK98932884T DK98932884T DK0991945T4 DK 0991945 T4 DK0991945 T4 DK 0991945T4 DK 98932884 T DK98932884 T DK 98932884T DK 98932884 T DK98932884 T DK 98932884T DK 0991945 T4 DK0991945 T4 DK 0991945T4
Authority
DK
Denmark
Prior art keywords
protein antigens
sera
patients
identification
identified
Prior art date
Application number
DK98932884T
Other languages
English (en)
Other versions
DK0991945T3 (da
Inventor
David Misek
Samir M Hanash
Robert Hinderer
Latha Prasanan
Original Assignee
Univ Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21967731&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0991945(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Michigan filed Critical Univ Michigan
Publication of DK0991945T3 publication Critical patent/DK0991945T3/da
Application granted granted Critical
Publication of DK0991945T4 publication Critical patent/DK0991945T4/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5752—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the lungs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK98932884T 1997-06-26 1998-06-26 Fremgangsmåde til identifikation af tumor-antigener med autoantistoffer i serum DK0991945T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5083297P 1997-06-26 1997-06-26
PCT/US1998/013295 WO1999000671A2 (en) 1997-06-26 1998-06-26 Method for identification of tumor antigens with autoantibodies in serum

Publications (2)

Publication Number Publication Date
DK0991945T3 DK0991945T3 (da) 2004-07-26
DK0991945T4 true DK0991945T4 (da) 2008-06-09

Family

ID=21967731

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98932884T DK0991945T4 (da) 1997-06-26 1998-06-26 Fremgangsmåde til identifikation af tumor-antigener med autoantistoffer i serum

Country Status (9)

Country Link
EP (1) EP0991945B2 (da)
JP (2) JP4065574B2 (da)
AT (1) ATE266203T1 (da)
AU (1) AU8267398A (da)
CA (2) CA2665707C (da)
DE (1) DE69823660D1 (da)
DK (1) DK0991945T4 (da)
ES (1) ES2216295T5 (da)
WO (1) WO1999000671A2 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0101285A2 (hu) * 1998-02-13 2001-08-28 Oxford Glycosciences (Uk) Ltd. Eljárások és készítmények a hepatóma diagnosztizálására
US6645465B2 (en) * 1999-08-06 2003-11-11 Michigan, University Of The Regents Annexin proteins and autoantibodies as serum markers for cancer
US6306615B1 (en) * 1999-08-19 2001-10-23 Tularik Inc. Detection method for monitoring β tubulin isotype specific modification
US7214498B2 (en) 2001-03-23 2007-05-08 Benaroya Research Institute At Virginia Mason Tumor associated antigens and methods of using the same
DE10151051B4 (de) * 2001-09-14 2007-07-12 Zeidler, Reinhard, Dr. Identifizierung von Antigenen durch xenogene, allogene oder autologe Antikörper-vermittelte Präzipitation
AU2002365228A1 (en) * 2001-11-09 2003-09-02 Brad Nelson Antigen panels and methods of using the same
GB2395270B (en) * 2002-11-14 2006-08-16 Univ Nottingham Tumour marker proteins and uses thereof
AU2003903317A0 (en) * 2003-06-27 2003-07-10 Proteome Systems Intellectual Property Pty Ltd Method of isolating a protein
US20090197285A1 (en) * 2005-11-10 2009-08-06 University Of Kentucky Lung Cancer Diagnostic Assay
JP2010507069A (ja) * 2006-07-08 2010-03-04 ユニバーシティー オブ ケンタッキー リサーチ ファンデーション 肺癌診断アッセイ
JP2011107064A (ja) * 2009-11-20 2011-06-02 Nitto Boseki Co Ltd クラスリン重鎖に対する自己抗体の免疫測定方法、それに用いるキット、及びそれを用いた癌判定方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2062675A1 (en) * 1991-04-09 1992-10-10 Sandra S. Fenton Endometrial antigen, composition, test kit and method for endometrial antibody determination
US5405749A (en) * 1991-12-06 1995-04-11 Polans; Arthur S. Method for identifying and purifying a cancer associated retinopathy autoantigen, and testing patient serum for the autoantibody to the autoantigen
AU6960694A (en) * 1993-05-28 1994-12-20 Medical University Of South Carolina Endometrial proteins, antigenic compositions and methods for detecting endometriosis

Also Published As

Publication number Publication date
ATE266203T1 (de) 2004-05-15
ES2216295T3 (es) 2004-10-16
JP2007333744A (ja) 2007-12-27
DK0991945T3 (da) 2004-07-26
EP0991945B1 (en) 2004-05-06
CA2665707A1 (en) 1999-01-07
WO1999000671A2 (en) 1999-01-07
EP0991945A2 (en) 2000-04-12
EP0991945B2 (en) 2008-02-20
DE69823660D1 (de) 2004-06-09
CA2665707C (en) 2013-02-12
WO1999000671A3 (en) 1999-06-10
AU8267398A (en) 1999-01-19
ES2216295T5 (es) 2008-06-01
JP2002508835A (ja) 2002-03-19
CA2294514C (en) 2009-09-01
CA2294514A1 (en) 1999-01-07
JP4065574B2 (ja) 2008-03-26

Similar Documents

Publication Publication Date Title
EP1734368B1 (en) Annexin autoantibodies used as markers for lung cancer
CY1112631T1 (el) ΜΕΘΟΔΟΙ ΤΑΥΤΟΠΟΙΗΣΗΣ ΟΓΚΩΝ ΠΟΥ ΑΠΟΚΡΙΝΟΝΤΑΙ ΣΕ ΑΓΩΓΗ ΜΕ ΑΝΤΙΣΩΜΑΤΑ ΑΝΤΙ-ΕrbB2
DE69929185D1 (de) Tumormarker
EP1565489A4 (en) NEW RAAG10 CELL SURFACE TARGET AND THIS GOAL DETECTING ANTIBODY FAMILY
CY1108450T1 (el) Μεθοδος για την ανιχνευση ν-τελικου προβνρ
ATE318147T1 (de) Spezifische monoklonale antikörperfür die extrazelluläre domäne von protasta-spezifischem membranantigen
TR200200937T2 (tr) Yumurtalık kanseri tedavisi için bileşimler.
DE69839123D1 (de) Prostattumor polynukleotid- und antigenzusammensetzungen
DK0991945T4 (da) Fremgangsmåde til identifikation af tumor-antigener med autoantistoffer i serum
IL142971A0 (en) S100 proteins and autoantibodies as serum markers for cancer
DE3780480D1 (de) Test fuer menschlichen brustkrebs.
DE69126038D1 (de) Diagnose von krebs-metastasen durch das mts-1 gen
KR830003898A (ko) 인체 암 핵인 항원에 대한 항체를 사용한 인체 암세포의 검출
WO2008099419A3 (en) Autoantibodies for protein antigens as markers for cancer of gingivo-buccal complex
Guilpain et al. A combined SDS‐PAGE and proteomics approach to identify target autoantigens in healthy individuals and patients with autoimmune diseases
Kennel Characterization of a tumor cell surface protein with heterologous antisera to a spontaneous BALB/c lung carcinoma
ATE532796T1 (de) Immunassays zur spezifischen bestimmung von scca- isoformen
NO168311C (no) Monoklonale antistoffer for humane ikke-smaacelle lungekarsinomer, cellelinjer som produserer disse samt diagnostisksett
FI20010868A0 (fi) Menetelmä ja välineet gluteenin indusoimien tautien havaitsemiseksi
ATE192236T1 (de) Menschliche phospholipase aktivierender proteinteil
EP1572931A4 (en) METHOD AND COMPOSITIONS FOR MODULATING AND DETECTING WISP ACTIVITY
WO2001065262A3 (en) Reagents and methods useful for detecting diseases of the breast
Evans et al. Biochemical and physical characterizations of tumor-associated fetal antigens
Kirkeby et al. Staining of electrophoretically separated enamel proteins
SE9900875D0 (sv) Antinuclear antibody assay utilizing stress-treated cells or cell extracts